146 related articles for article (PubMed ID: 5456078)
21. [Induction of specific resistance in Swiss mice using x-irradiated cells of the ATPC+ ascitic tumor].
Marconi P; Fimiani E; Bistoni F; Latini A
Boll Soc Ital Biol Sper; 1973 May; 49(10):529-33. PubMed ID: 4132961
[No Abstract] [Full Text] [Related]
22. [Experimental chemotherapy of mammary neoplasms. A review].
Schönenberger H; Kranzfelder G; Hoffmann E; Egginger G; Schmitt H; Taneja AK
Pharmazie; 1976; 31(9):590-7. PubMed ID: 798208
[No Abstract] [Full Text] [Related]
23. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
Sartorelli AC; Booth BA
Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
[No Abstract] [Full Text] [Related]
24. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
Greager JA; Baldwin RW
Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
[No Abstract] [Full Text] [Related]
25. Enzymically-mediated changes in murine mammary adenocarcinoma cell membrane induces changes in lymphoid tissue immune ribonucleic acids.
Hakim AA
Arch Geschwulstforsch; 1980; 50(7):613-27. PubMed ID: 6165333
[TBL] [Abstract][Full Text] [Related]
26. [Therapy experiments on autochthonic mammary carcinoma in rats].
Fretz J; Rohde W; Schmähl D; Thomas C
Arzneimittelforschung; 1969 Aug; 19(8):1291-5. PubMed ID: 5820295
[No Abstract] [Full Text] [Related]
27. Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma.
Cavallo F; Di Pierro F; Giovarelli M; Gulino A; Vacca A; Stoppacciaro A; Forni M; Modesti A; Forni G
Cancer Res; 1993 Nov; 53(21):5067-70. PubMed ID: 8221636
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy of tumors. 3. Chemical review of natural antineoplastic agents: antibiotics and related compounds; enzymes and hormones].
Artico M
Farmaco Sci; 1974 Aug; 29(8):598-646. PubMed ID: 4136312
[No Abstract] [Full Text] [Related]
29. Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors.
Frost P; Kerbel RS; Bauer E; Tartamella-Biondo R; Cefalu W
Cancer Res; 1983 Jan; 43(1):125-32. PubMed ID: 6401163
[No Abstract] [Full Text] [Related]
30. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
Haskill S; Ritter F; Becker S
J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
[No Abstract] [Full Text] [Related]
31. Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
Magnarin M; Bergamo A; Carotenuto ME; Zorzet S; Sava G
Anticancer Res; 2000; 20(5A):2939-44. PubMed ID: 11062704
[TBL] [Abstract][Full Text] [Related]
32. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.
Kusmartsev S; Cheng F; Yu B; Nefedova Y; Sotomayor E; Lush R; Gabrilovich D
Cancer Res; 2003 Aug; 63(15):4441-9. PubMed ID: 12907617
[TBL] [Abstract][Full Text] [Related]
33. Can neo-adjuvant chemotherapy prevent residual tumors?
Bourut C; Chenu E; Mathé G
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():59-63. PubMed ID: 2977811
[No Abstract] [Full Text] [Related]
34. Actinomycin D and x-radiation suppression of spontaneous tumorigenesis in mice.
Mason JM; Jennings BR
J Reticuloendothel Soc; 1974 Feb; 15(2):96-111. PubMed ID: 4815216
[No Abstract] [Full Text] [Related]
35. Influence of myelobromol on growth and metabolism of experimental tumours.
Friborský V
Ther Hung; 1969; 17(1):23-7. PubMed ID: 5820143
[No Abstract] [Full Text] [Related]
36. Enhanced lymphocytic action on breast tumor.
Davidson AT
J Natl Med Assoc; 1974 Nov; 66(6):472-4. PubMed ID: 4436878
[No Abstract] [Full Text] [Related]
37. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. II. Active immunization of mammary-tumor-agent-free mice.
Suit HD; Silobrcic V
J Natl Cancer Inst; 1967 Dec; 39(6):1121-8. PubMed ID: 6079865
[No Abstract] [Full Text] [Related]
38. [Combination of chemotherapy and immunotherapy in the treatment of carcinoma of the mammary gland in mice (author's transl)].
Turić M; Malenica B; Rogan-Grgas J; Milas L
Lijec Vjesn; 1978 May; 100(5):289-94. PubMed ID: 682831
[No Abstract] [Full Text] [Related]
39. Inhibition of antitumor effects of flavone acetic acid by cortisone.
Ching LM; Joseph WR; Baguley BC
Anticancer Res; 1993; 13(4):1139-41. PubMed ID: 8352536
[TBL] [Abstract][Full Text] [Related]
40. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer.
Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abulsamad K; Adams SL
Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
